Zurich and Axa XL battle Giant Eagle over opioid defence costs
  • X
  • LinkedIn
  • Show more sharing options
  • Print
  • X
  • LinkedIn

© 2024 Insider International Limited, company number 15236286, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian Group. All rights reserved.


Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Zurich and Axa XL battle Giant Eagle over opioid defence costs

Bernard Goyder
January 15, 2020
  • X
  • LinkedIn
  • Show more sharing options
  • Print
  • X
  • LinkedIn
Narcotic drugs (opioids)

Zurich and Axa XL told a Pennsylvania federal judge they shouldn’t have to cover opioid-related defence costs for supermarket chain Giant Eagle because the retailer hasn’t yet exhausted its primary coverage.  

Carriers

Request a free trial:

Fuel a smarter strategy with our actionable market intelligence

    • Gain a competitive edge and accelerate decision-making
    • Be empowered by insights that transform confusion to clarity
    • Uncover growth opportunities and prepare for potential threats
Request a free trial Already a subscriber? Login now

Topics

NewsAxa XLZurichCasualty/GLRegulation
BG
Bernard Goyder
Gift this article